ID: ALA4168633

Max Phase: Preclinical

Molecular Formula: C31H31Br2NO5

Molecular Weight: 657.40

Molecule Type: Small molecule

Representations

Canonical SMILES:  CC1(C)CC(=O)C2=C(C1)NC1=C(C(=O)CC(C)(C)C1)C2c1cc(Br)c(OCc2ccc(C(=O)O)cc2)c(Br)c1

Standard InChI:  InChI=1S/C31H31Br2NO5/c1-30(2)11-21-26(23(35)13-30)25(27-22(34-21)12-31(3,4)14-24(27)36)18-9-19(32)28(20(33)10-18)39-15-16-5-7-17(8-6-16)29(37)38/h5-10,25,34H,11-15H2,1-4H3,(H,37,38)

Standard InChI Key:  HDESYCKIVOTMPG-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 657.40

Molecular Weight (Monoisotopic): 655.0569

AlogP: 7.46

#Rotatable Bonds: 5

Polar Surface Area: 92.70

Molecular Species: ACID

HBA: 5

HBD: 2

#RO5 Violations: 2

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 4.06

CX Basic pKa:

CX LogP: 6.34

CX LogD: 3.22

Aromatic Rings: 2

Heavy Atoms: 39

QED Weighted: 0.35

Np Likeness Score: -0.33

References

1. Xiong H, Han J, Wang J, Lu W, Wang C, Chen Y, Fulin Lian, Zhang N, Liu YC, Zhang C, Ding H, Jiang H, Lu W, Luo C, Zhou B..  (2018)  Discovery of 1,8-acridinedione derivatives as novel GCN5 inhibitors via high throughput screening.,  151  [PMID:29665527] [10.1016/j.ejmech.2018.02.005]

Source

Source(1):

• Scientific Literature